Free Trial

Lam Research (LRCX) Financials

Lam Research logo
$294.05 +7.53 (+2.63%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$294.17 +0.12 (+0.04%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Lam Research

Annual Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/28/2015 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025
Net Income / (Loss) Attributable to Common Shareholders
656 914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358
Consolidated Net Income / (Loss)
656 914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358
Net Income / (Loss) Continuing Operations
656 914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358
Total Pre-Tax Income
741 960 1,812 3,152 2,447 2,575 4,371 5,193 5,109 4,360 5,958
Total Operating Income
788 1,074 1,902 3,213 2,465 2,674 4,482 5,382 5,175 4,264 5,901
Total Gross Profit
2,284 2,619 3,603 5,165 4,358 4,609 6,805 7,872 7,777 7,053 8,979
Total Revenue
5,259 5,886 8,014 11,077 9,654 10,045 14,626 17,227 17,429 14,905 18,436
Operating Revenue
5,259 5,886 8,014 11,077 9,654 10,045 14,626 17,227 17,429 14,905 18,436
Total Cost of Revenue
2,975 3,267 4,410 5,912 5,295 5,436 7,821 9,355 9,652 7,853 9,457
Operating Cost of Revenue
2,975 3,267 4,410 5,912 5,295 5,436 7,821 9,355 9,652 7,809 9,457
Total Operating Expenses
1,496 1,545 1,701 1,952 1,894 1,935 2,323 2,490 2,602 2,789 3,078
Selling, General & Admin Expense
592 631 667 762 702 682 830 886 833 868 982
Research & Development Expense
825 914 1,034 1,190 1,191 1,252 1,493 1,604 1,727 1,902 2,096
Total Other Income / (Expense), net
-47 -114 -90 -62 -18 -99 -111 -189 -66 96 57
Other Income / (Expense), net
-47 -114 -90 -62 -18 -99 -111 -189 -66 96 57
Income Tax Expense
85 46 114 771 255 323 462 588 598 532 600
Basic Earnings per Share
$4.11 $5.75 $10.47 $14.73 $14.37 $15.55 $27.22 $32.92 $3.33 $2.91 $4.17
Weighted Average Basic Shares Outstanding
159.63M 158.92M 162.22M 161.64M 152.48M 144.81M 143.61M 139.90M 1.35B 1.31B 1.29B
Diluted Earnings per Share
$3.70 $5.22 $9.24 $13.17 $13.70 $15.10 $26.90 $32.75 $3.32 $2.90 $4.15
Weighted Average Diluted Shares Outstanding
177.07M 175.16M 183.77M 180.78M 159.92M 149.09M 145.32M 140.63M 1.36B 1.32B 1.29B
Weighted Average Basic & Diluted Shares Outstanding
159.50M 159M 162.20M 161.60M 144.53M 145.63M 141.95M 136.99M 132.51M 129.88M 1.27B

Quarterly Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/24/2023 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026
Net Income / (Loss) Attributable to Common Shareholders
887 954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825
Consolidated Net Income / (Loss)
887 954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825
Net Income / (Loss) Continuing Operations
887 954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825
Total Pre-Tax Income
1,026 1,087 1,093 1,154 1,294 1,348 1,537 1,779 1,859 1,837 2,012
Total Operating Income
1,023 1,057 1,057 1,127 1,264 1,334 1,562 1,741 1,829 1,810 2,047
Total Gross Profit
1,655 1,757 1,801 1,840 2,003 2,073 2,314 2,590 2,685 2,651 2,911
Total Revenue
3,482 3,758 3,794 3,872 4,168 4,376 4,720 5,171 5,324 5,345 5,841
Operating Revenue
3,482 3,758 3,794 3,872 4,168 4,376 4,720 5,171 5,324 5,345 5,841
Total Cost of Revenue
1,827 2,001 1,993 2,031 2,165 2,303 2,406 2,582 2,639 2,694 2,931
Operating Cost of Revenue
1,819 1,986 1,993 2,011 2,165 2,303 2,406 2,582 2,639 2,694 2,931
Total Operating Expenses
632 700 743 714 738 739 752 849 856 841 864
Selling, General & Admin Expense
207 229 216 216 243 244 226 268 279 268 280
Research & Development Expense
423 470 512 498 495 495 526 580 576 573 583
Total Other Income / (Expense), net
2.60 30 36 28 30 14 -25 38 30 26 -35
Other Income / (Expense), net
2.60 30 36 28 30 14 -25 38 30 26 -35
Income Tax Expense
138 133 127 134 178 157 206 59 291 243 186
Basic Earnings per Share
$0.67 $0.72 $0.74 $7.81 $0.86 $0.93 $1.04 $1.34 $1.24 $1.27 $1.46
Weighted Average Basic Shares Outstanding
1.33B 1.32B 1.31B 131.41M 1.30B 1.29B 1.28B 1.29B 1.26B 1.25B 1.25B
Diluted Earnings per Share
$0.67 $0.72 $0.73 $7.78 $0.86 $0.92 $1.03 $1.34 $1.24 $1.26 $1.45
Weighted Average Diluted Shares Outstanding
1.33B 1.32B 1.32B 132.00M 1.30B 1.29B 1.29B 1.29B 1.27B 1.26B 1.26B
Weighted Average Basic & Diluted Shares Outstanding
131.79M 131.10M 130.74M 129.88M 1.29B 1.28B 1.28B 1.27B 1.26B 1.25B 1.25B
Cash Dividends to Common per Share
- - - - - $0.23 $0.23 $0.23 - $0.26 $0.26

Annual Cash Flow Statements for Lam Research

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/28/2015 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025
Net Change in Cash & Equivalents
831 3,811 -2,656 2,135 -855 1,256 -498 -897 1,814 263 557
Net Cash From Operating Activities
666 1,295 2,029 2,656 3,176 2,126 3,588 3,100 5,179 4,652 6,173
Net Cash From Continuing Operating Activities
666 1,295 2,029 2,656 3,176 2,126 3,588 3,100 5,179 4,652 6,173
Net Income / (Loss) Continuing Operations
656 914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358
Consolidated Net Income / (Loss)
656 914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358
Depreciation Expense
278 291 307 326 309 269 307 334 342 360 386
Non-Cash Adjustments To Reconcile Net Income
148 191 166 248 189 196 203 214 339 303 350
Changes in Operating Assets and Liabilities, net
-415 -101 -167 -314 487 -590 -830 -2,054 -13 161 79
Net Cash From Investing Activities
-194 469 -2,053 2,749 -1,637 -244 73 612 -535 -371 -708
Net Cash From Continuing Investing Activities
-194 469 -2,053 2,749 -1,637 -244 73 612 -535 -371 -708
Purchase of Property, Plant & Equipment
-198 -175 -157 -273 -303 -203 -349 -546 -502 -397 -759
Acquisitions
- - 0.00 -116 - - 0.00 0.00 -120 0.00 0.00
Sale and/or Maturity of Investments
- 643 2,698 5,686 1,604 2,883 3,854 1,734 98 38 0.00
Other Investing Activities, net
3.98 1.64 -13 -15 -7.36 -26 -42 -7.58 -11 -12 51
Net Cash From Financing Activities
369 2,048 -2,632 -3,272 -2,390 -624 -4,167 -4,579 -2,831 -3,996 -4,937
Net Cash From Continuing Financing Activities
369 2,048 -2,632 -3,272 -2,390 -624 -4,167 -4,579 -2,831 -3,996 -4,937
Repayment of Debt
-0.66 -0.49 -1,688 -1,506 -493 -1,916 -864 -12 -27 -270 -507
Repurchase of Common Equity
-573 -158 -812 -2,653 -3,781 -1,370 -2,698 -3,866 -2,017 -2,843 -3,422
Payment of Dividends
-116 -190 -243 -308 -678 -657 -727 -815 -908 -1,019 -1,150
Issuance of Common Equity
66 59 73 85 85 94 122 114 121 136 143
Effect of Exchange Rate Changes
-9.02 -0.72 -0.06 2.59 -4.04 -2.75 7.22 -30 0.13 -22 28
Cash Interest Paid
- - 105 84 77 172 204 176 175 173 172
Cash Income Taxes Paid
115 40 28 143 300 223 519 808 810 992 973

Quarterly Cash Flow Statements for Lam Research

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/24/2023 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026
Net Change in Cash & Equivalents
-461 499 48 177 221 -395 -214 945 304 -516 -1,429
Net Cash From Operating Activities
951 1,454 1,385 862 1,568 742 1,309 2,554 1,779 1,480 1,141
Net Cash From Continuing Operating Activities
951 1,454 1,385 862 1,568 742 1,309 2,554 1,779 1,480 1,141
Net Income / (Loss) Continuing Operations
887 954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825
Consolidated Net Income / (Loss)
887 954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825
Depreciation Expense
90 91 90 88 94 96 97 98 102 104 116
Non-Cash Adjustments To Reconcile Net Income
67 74 87 75 80 73 89 109 95 69 94
Changes in Operating Assets and Liabilities, net
-94 335 242 -321 278 -619 -208 627 13 -286 -894
Net Cash From Investing Activities
-75 -102 -92 -102 -111 -175 -293 -129 -186 -258 -335
Net Cash From Continuing Investing Activities
-75 -102 -92 -102 -111 -175 -293 -129 -186 -258 -335
Purchase of Property, Plant & Equipment
-77 -115 -104 -101 -111 -188 -288 -172 -185 -261 -332
Other Investing Activities, net
-4.97 -2.52 -3.36 -0.87 0.04 13 -4.86 43 -0.93 3.10 -2.98
Net Cash From Financing Activities
-1,326 -860 -1,236 -574 -1,259 -935 -1,233 -1,510 -1,282 -1,725 -2,231
Net Cash From Continuing Financing Activities
-1,326 -860 -1,236 -574 -1,259 -935 -1,233 -1,510 -1,282 -1,725 -2,231
Repayment of Debt
-255 -4.81 -0.76 -8.82 -1.26 -0.27 -504 -2.31 -14 -2.58 -751
Repurchase of Common Equity
-843 -645 -981 -374 -997 -698 -435 -1,292 -976 -1,466 -1,163
Payment of Dividends
-230 -264 -263 -261 -261 -298 -296 -295 -292 -328 -326
Issuance of Common Equity
2.82 55 8.24 70 -0.04 60 1.99 80 0.00 71 9.17
Effect of Exchange Rate Changes
-11 6.73 -8.45 -9.62 23 -26 2.38 29 -7.06 -13 -4.98

Annual Balance Sheets for Lam Research

This table presents Lam Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/28/2015 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025
Total Assets
9,365 12,264 12,123 12,479 12,001 14,559 15,892 17,196 18,782 18,745 21,345
Total Current Assets
6,271 9,213 9,142 9,150 8,560 10,854 11,652 12,285 13,228 12,883 14,517
Cash & Equivalents
1,502 5,039 2,378 4,512 3,658 4,915 4,418 3,522 5,337 5,848 6,391
Accounts Receivable
1,094 1,262 1,673 2,177 1,456 2,097 3,026 4,314 2,823 2,519 3,378
Inventories, net
943 972 1,233 1,876 1,540 1,900 2,689 3,966 4,816 4,218 4,308
Prepaid Expenses
157 151 195 147 134 146 208 347 252 298 440
Plant, Property, & Equipment, net
621 640 686 903 0.00 0.00 0.00 1,648 1,857 2,155 2,429
Total Noncurrent Assets
2,472 2,412 2,295 2,427 3,441 3,706 4,240 3,263 3,697 3,707 4,400
Goodwill
1,388 1,386 1,386 1,485 1,485 1,484 1,490 1,515 1,622 1,765 1,809
Other Noncurrent Operating Assets
186 210 242 368 1,484 1,799 2,365 1,394 1,906 1,942 2,591
Total Liabilities & Shareholders' Equity
9,365 12,264 12,123 12,479 12,001 14,559 15,892 17,196 18,782 18,745 21,345
Total Liabilities
4,020 6,162 5,135 5,899 7,278 9,376 9,865 10,917 10,571 10,205 11,484
Total Current Liabilities
2,631 2,418 2,950 3,150 2,372 3,162 3,528 4,565 4,185 4,338 6,568
Short-Term Debt
1,360 948 908 610 667 840 11 7.38 8.36 505 754
Accounts Payable
300 348 465 511 377 592 830 1,011 471 614 854
Accrued Expenses
649 773 969 1,309 947 1,273 1,719 1,974 2,011 1,802 2,394
Current Deferred Revenue
322 349 608 720 381 458 967 - 1,695 1,418 2,566
Total Noncurrent Liabilities
1,388 3,744 2,185 2,749 4,906 6,213 6,337 6,353 6,387 5,867 4,915
Long-Term Debt
1,001 3,378 1,785 1,807 3,823 4,971 4,990 4,998 5,003 4,479 3,730
Noncurrent Deferred Revenue
203 232 120 852 893 910 948 931 882 813 603
Other Noncurrent Operating Liabilities
184 135 280 91 191 333 399 423 501 575 582
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,103 5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862
Total Preferred & Common Equity
5,103 5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,103 5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862
Common Stock
5,367 5,573 5,846 6,145 6,410 6,696 7,053 7,415 7,809 8,224 8,699
Retained Earnings
4,097 4,820 6,250 8,261 9,931 11,521 14,685 18,455 22,032 24,811 28,989
Treasury Stock
-4,303 -4,429 -5,216 -7,846 -11,603 -12,950 -15,647 -19,481 -21,530 -24,366 -27,763
Accumulated Other Comprehensive Income / (Loss)
-58 -69 -62 -57 -64 -94 -64 -110 -101 -130 -62

Quarterly Balance Sheets for Lam Research

This table presents Lam Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/25/2023 9/24/2023 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 9/28/2025 12/28/2025 3/29/2026
Total Assets
18,782 18,538 18,784 18,280 18,745 19,532 19,840 19,968 21,900 21,391 20,792
Total Current Assets
13,228 12,994 13,055 12,488 12,883 13,492 13,613 13,460 14,807 14,018 13,297
Cash & Equivalents
5,337 5,126 5,623 5,672 5,848 6,067 5,665 5,451 6,693 6,180 4,751
Accounts Receivable
2,823 2,811 2,707 2,204 2,519 2,937 3,305 3,228 3,633 3,492 4,133
Inventories, net
4,816 4,748 4,430 4,323 4,218 4,210 4,358 4,463 4,095 4,038 4,000
Prepaid Expenses
252 278 279 290 298 278 284 318 386 308 413
Plant, Property, & Equipment, net
1,857 2,111 2,147 2,182 2,155 2,214 2,314 2,372 2,511 2,711 2,854
Total Noncurrent Assets
3,697 3,434 3,582 3,609 3,707 3,826 3,913 4,136 4,583 4,662 4,641
Goodwill
1,622 1,626 1,627 1,627 1,765 1,758 1,761 1,795 1,827 1,864 1,882
Other Noncurrent Operating Assets
1,906 1,650 1,804 1,840 1,942 2,068 2,152 2,341 2,756 2,798 2,759
Total Liabilities & Shareholders' Equity
18,782 18,538 18,784 18,280 18,745 19,532 19,840 19,968 21,900 21,391 20,792
Total Liabilities
10,571 10,491 10,561 10,258 10,205 11,061 11,032 10,457 11,707 11,246 10,207
Total Current Liabilities
4,185 4,247 4,272 4,430 4,338 5,343 5,350 5,490 6,708 6,213 5,242
Short-Term Debt
8.36 3.86 3.78 505 505 505 504 754 754 754 4.10
Accounts Payable
471 528 500 532 614 704 822 853 863 1,027 1,072
Accrued Expenses
2,011 2,120 1,976 1,792 1,802 2,196 2,096 2,000 2,444 2,267 2,075
Current Deferred Revenue
1,695 1,595 - 1,602 1,418 1,937 - 1,882 2,646 2,165 2,091
Total Noncurrent Liabilities
6,387 6,244 6,289 5,827 5,867 5,718 5,682 4,967 5,000 5,033 4,965
Long-Term Debt
5,003 4,980 4,980 4,478 4,479 4,479 4,478 3,730 3,730 3,730 3,730
Noncurrent Deferred Revenue
882 781 798 832 813 665 670 691 646 668 622
Other Noncurrent Operating Liabilities
501 483 511 517 575 574 534 547 624 635 613
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8,210 8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585
Total Preferred & Common Equity
8,210 8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
8,210 8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585
Common Stock
7,809 7,879 7,997 8,082 8,224 8,304 8,441 8,530 8,796 8,950 9,055
Retained Earnings
22,032 22,655 23,347 24,052 24,811 25,630 26,525 27,561 30,230 31,498 32,998
Treasury Stock
-21,530 -22,366 -23,004 -23,985 -24,366 -25,375 -26,024 -26,456 -28,760 -30,204 -31,348
Accumulated Other Comprehensive Income / (Loss)
-101 -121 -118 -128 -130 -88 -134 -124 -74 -99 -121

Annual Metrics And Ratios for Lam Research

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/28/2015 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
14.15% 11.91% 36.15% 38.23% -12.85% 4.05% 45.61% 17.78% 1.17% -14.48% 23.68%
EBITDA Growth
0.31% 22.81% 71.35% 62.91% -21.09% 3.18% 64.51% 18.15% -1.36% -13.42% 34.42%
EBIT Growth
2.42% 29.60% 88.69% 73.97% -22.38% 5.25% 69.74% 18.81% -1.62% -14.66% 36.65%
NOPAT Growth
17.72% 46.66% 74.29% 36.16% -9.04% 5.91% 71.41% 19.08% -4.27% -18.07% 41.77%
Net Income Growth
3.68% 39.43% 85.74% 40.22% -7.95% 2.75% 73.57% 17.83% -2.05% -15.14% 39.98%
EPS Growth
2.21% 41.08% 77.01% 42.53% 4.02% 10.22% 78.15% 21.75% 1.40% -12.68% 43.10%
Operating Cash Flow Growth
-11.54% 94.38% 56.70% 30.87% 19.59% -33.05% 68.74% -13.61% 67.08% -10.17% 32.69%
Free Cash Flow Firm Growth
0.58% 96.74% 54.53% 15.50% 22.37% -25.76% 62.99% -18.25% 66.02% -2.62% 27.15%
Invested Capital Growth
3.66% -3.15% 1.01% 12.04% -6.96% 14.27% 25.24% 46.12% 6.91% -2.66% 3.66%
Revenue Q/Q Growth
4.63% 1.11% 11.07% 7.59% -7.34% 4.48% 10.20% 2.93% -7.57% 4.66% 7.59%
EBITDA Q/Q Growth
-10.52% 10.23% 19.57% 11.34% -11.96% 5.35% 13.82% 1.09% -8.30% 6.53% 11.12%
EBIT Q/Q Growth
-13.82% 13.11% 21.57% 12.68% -12.48% 5.70% 14.71% 0.98% -8.84% 7.14% 11.71%
NOPAT Q/Q Growth
-2.67% 15.46% 15.83% 25.60% -17.56% 7.15% 12.52% 3.58% -10.21% 5.70% 14.93%
Net Income Q/Q Growth
-13.48% 16.23% 18.70% 26.23% -17.95% 7.38% 12.95% 1.42% -8.26% 6.03% 15.02%
EPS Q/Q Growth
-12.94% 16.00% 17.86% 27.37% -13.84% 8.71% 13.69% 2.50% -7.52% 6.38% 14.33%
Operating Cash Flow Q/Q Growth
-40.88% 57.34% 30.34% -1.75% 5.38% -3.07% 21.01% -24.24% 15.08% -5.30% 37.75%
Free Cash Flow Firm Q/Q Growth
-7.48% 24.23% 11.70% -1.43% 7.44% -4.37% 24.56% -26.52% 8.97% -1.19% 47.58%
Invested Capital Q/Q Growth
-1.63% -4.05% -2.33% 13.24% -5.32% 1.05% -1.98% 14.71% 1.18% 4.66% -6.90%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.43% 44.49% 44.97% 46.63% 45.15% 45.88% 46.53% 45.69% 44.62% 47.32% 48.71%
EBITDA Margin
19.37% 21.26% 26.75% 31.53% 28.55% 28.31% 31.98% 32.08% 31.28% 31.67% 34.41%
Operating Margin
14.98% 18.25% 23.74% 29.01% 25.53% 26.62% 30.64% 31.24% 29.69% 28.61% 32.01%
EBIT Margin
14.09% 16.31% 22.61% 28.45% 25.34% 25.64% 29.88% 30.15% 29.32% 29.25% 32.32%
Profit (Net Income) Margin
12.47% 15.53% 21.19% 21.49% 22.70% 22.42% 26.72% 26.73% 25.88% 25.68% 29.06%
Tax Burden Percent
88.49% 95.20% 93.71% 75.53% 89.57% 87.45% 89.42% 88.68% 88.29% 87.79% 89.93%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
11.51% 4.80% 6.29% 24.47% 10.43% 12.55% 10.58% 11.32% 11.71% 12.21% 10.07%
Return on Invested Capital (ROIC)
20.53% 30.04% 52.95% 67.66% 60.34% 61.88% 88.31% 76.84% 59.88% 48.11% 67.90%
ROIC Less NNEP Spread (ROIC-NNEP)
22.74% 34.73% 55.62% 69.12% 61.16% 69.24% 97.63% -210.15% 44.85% 33.91% 64.19%
Return on Net Nonoperating Assets (RNNOA)
-8.11% -14.07% -27.01% -32.57% -21.56% -16.42% -18.58% -1.99% 2.39% -2.41% -9.67%
Return on Equity (ROE)
12.42% 15.97% 25.94% 35.09% 38.77% 45.46% 69.73% 74.85% 62.27% 45.71% 58.24%
Cash Return on Invested Capital (CROIC)
16.93% 33.24% 51.95% 56.31% 67.55% 48.56% 65.89% 39.36% 53.20% 50.81% 64.31%
Operating Return on Assets (OROA)
8.54% 8.88% 14.86% 25.62% 19.99% 19.39% 28.71% 31.39% 28.40% 23.24% 29.72%
Return on Assets (ROA)
7.55% 8.45% 13.92% 19.35% 17.90% 16.96% 25.67% 27.84% 25.08% 20.40% 26.73%
Return on Common Equity (ROCE)
11.92% 15.34% 25.19% 34.45% 38.34% 45.18% 69.66% 74.85% 62.27% 45.71% 58.24%
Return on Equity Simple (ROE_SIMPLE)
12.85% 15.51% 24.90% 36.62% 46.89% 43.53% 64.85% 73.35% 54.94% 44.82% 0.00%
Net Operating Profit after Tax (NOPAT)
697 1,023 1,783 2,427 2,208 2,338 4,008 4,773 4,569 3,743 5,307
NOPAT Margin
13.26% 17.38% 22.24% 21.91% 22.87% 23.28% 27.40% 27.70% 26.22% 25.11% 28.79%
Net Nonoperating Expense Percent (NNEP)
-2.22% -4.68% -2.67% -1.45% -0.82% -7.36% -9.32% 286.99% 15.03% 14.21% 3.71%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 36.99%
Cost of Revenue to Revenue
56.57% 55.51% 55.03% 53.37% 54.85% 54.12% 53.47% 54.31% 55.38% 52.68% 51.30%
SG&A Expenses to Revenue
11.25% 10.72% 8.33% 6.88% 7.28% 6.79% 5.67% 5.14% 4.78% 5.83% 5.33%
R&D to Revenue
15.69% 15.52% 12.90% 10.74% 12.34% 12.47% 10.21% 9.31% 9.91% 12.76% 11.37%
Operating Expenses to Revenue
28.45% 26.24% 21.23% 17.62% 19.62% 19.26% 15.88% 14.45% 14.93% 18.71% 16.70%
Earnings before Interest and Taxes (EBIT)
741 960 1,812 3,152 2,447 2,575 4,371 5,193 5,109 4,360 5,958
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,019 1,251 2,144 3,493 2,756 2,844 4,678 5,527 5,452 4,720 6,344
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.25 1.98 3.24 4.03 5.65 8.11 14.41 9.71 9.86 16.30 12.61
Price to Tangible Book Value (P/TBV)
3.84 2.96 4.39 5.57 8.88 11.92 19.71 13.08 12.62 20.55 15.44
Price to Revenue (P/Rev)
2.18 1.98 2.75 2.36 2.73 4.18 5.94 3.54 4.65 9.34 6.74
Price to Earnings (P/E)
17.50 12.76 13.00 10.99 12.04 18.63 22.22 13.24 17.95 36.37 23.20
Dividend Yield
1.16% 1.64% 1.21% 1.60% 2.50% 1.59% 0.85% 1.36% 1.14% 0.75% 0.95%
Earnings Yield
5.71% 7.83% 7.69% 9.10% 8.30% 5.37% 4.50% 7.55% 5.57% 2.75% 4.31%
Enterprise Value to Invested Capital (EV/IC)
2.84 2.72 5.51 6.19 7.16 10.13 17.01 8.42 10.23 18.03 15.39
Enterprise Value to Revenue (EV/Rev)
1.87 1.55 2.32 2.12 2.61 4.06 5.87 3.60 4.63 9.28 6.64
Enterprise Value to EBITDA (EV/EBITDA)
9.65 7.29 8.69 6.72 9.16 14.35 18.35 11.23 14.80 29.31 19.30
Enterprise Value to EBIT (EV/EBIT)
13.27 9.50 10.28 7.44 10.32 15.85 19.64 11.95 15.79 31.73 20.55
Enterprise Value to NOPAT (EV/NOPAT)
14.09 8.92 10.45 9.67 11.43 17.45 21.42 13.01 17.65 36.96 23.07
Enterprise Value to Operating Cash Flow (EV/OCF)
14.75 7.04 9.18 8.83 7.95 19.19 23.93 20.03 15.57 29.74 19.83
Enterprise Value to Free Cash Flow (EV/FCFF)
17.09 8.06 10.65 11.62 10.21 22.24 28.70 25.39 19.87 35.00 24.36
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.44 0.71 0.39 0.37 0.95 1.12 0.83 0.80 0.61 0.58 0.45
Long-Term Debt to Equity
0.19 0.55 0.26 0.27 0.81 0.96 0.83 0.80 0.61 0.52 0.38
Financial Leverage
-0.36 -0.41 -0.49 -0.47 -0.35 -0.24 -0.19 0.01 0.05 -0.07 -0.15
Leverage Ratio
1.64 1.89 1.86 1.81 2.17 2.68 2.72 2.69 2.48 2.24 2.18
Compound Leverage Factor
1.64 1.89 1.86 1.81 2.17 2.68 2.72 2.69 2.48 2.24 2.18
Debt to Total Capital
30.64% 41.48% 27.82% 26.86% 48.73% 52.85% 45.35% 44.36% 37.90% 36.85% 31.26%
Short-Term Debt to Total Capital
17.64% 9.09% 9.38% 6.78% 7.24% 7.64% 0.10% 0.07% 0.06% 3.73% 5.26%
Long-Term Debt to Total Capital
12.99% 32.40% 18.44% 20.08% 41.49% 45.21% 45.25% 44.30% 37.84% 33.12% 26.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.14% 1.99% 1.75% 0.87% 0.54% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.22% 56.53% 70.42% 72.27% 50.73% 47.05% 54.65% 55.64% 62.10% 63.15% 68.74%
Debt to EBITDA
2.32 3.46 1.26 0.69 1.63 2.04 1.07 0.91 0.92 1.06 0.71
Net Debt to EBITDA
-1.85 -2.20 -1.68 -0.80 -0.43 -0.41 -0.21 0.20 -0.06 -0.18 -0.30
Long-Term Debt to EBITDA
0.98 2.70 0.83 0.52 1.39 1.75 1.07 0.90 0.92 0.95 0.59
Debt to NOPAT
3.39 4.23 1.51 1.00 2.03 2.49 1.25 1.05 1.10 1.33 0.85
Net Debt to NOPAT
-2.71 -2.69 -2.02 -1.15 -0.54 -0.49 -0.24 0.23 -0.07 -0.23 -0.36
Long-Term Debt to NOPAT
1.44 3.30 1.00 0.74 1.73 2.13 1.25 1.05 1.10 1.20 0.70
Altman Z-Score
3.61 3.09 5.07 5.89 5.43 5.70 9.02 7.39 8.64 12.15 10.63
Noncontrolling Interest Sharing Ratio
4.03% 3.93% 2.88% 1.83% 1.13% 0.61% 0.10% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.38 3.81 3.10 2.90 3.61 3.43 3.30 2.69 3.16 2.97 2.21
Quick Ratio
1.96 3.35 2.62 2.26 2.90 2.79 2.48 1.75 1.95 1.93 1.49
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
575 1,132 1,749 2,020 2,472 1,835 2,991 2,445 4,059 3,953 5,026
Operating Cash Flow to CapEx
336.02% 738.60% 1,299.76% 971.13% 1,046.49% 1,046.28% 1,027.84% 567.67% 1,032.55% 1,172.83% 813.14%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.61 0.54 0.66 0.90 0.79 0.76 0.96 1.04 0.97 0.79 0.92
Accounts Receivable Turnover
5.55 5.00 5.46 5.75 5.32 5.65 5.71 4.69 4.88 5.58 6.25
Inventory Turnover
3.53 3.41 4.00 3.80 3.10 3.16 3.41 2.81 2.20 1.74 2.22
Fixed Asset Turnover
9.03 9.34 12.09 13.95 0.00 0.00 0.00 0.00 9.95 7.43 8.04
Accounts Payable Turnover
11.36 10.08 10.85 12.12 11.93 11.22 11.00 10.16 13.03 14.48 12.88
Days Sales Outstanding (DSO)
65.73 73.04 66.85 63.44 68.67 64.55 63.93 77.76 74.74 65.41 58.38
Days Inventory Outstanding (DIO)
103.30 106.99 91.24 95.98 117.75 115.49 107.09 129.84 166.07 209.96 164.54
Days Payable Outstanding (DPO)
32.13 36.22 33.64 30.12 30.59 32.53 33.18 35.91 28.02 25.21 28.33
Cash Conversion Cycle (CCC)
136.90 143.81 124.45 129.30 155.83 147.51 137.84 171.68 212.78 250.17 194.59
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,459 3,350 3,383 3,791 3,527 4,030 5,047 7,375 7,885 7,675 7,955
Invested Capital Turnover
1.55 1.73 2.38 3.09 2.64 2.66 3.22 2.77 2.28 1.92 2.36
Increase / (Decrease) in Invested Capital
122 -109 34 407 -264 503 1,017 2,328 510 -210 281
Enterprise Value (EV)
9,829 9,122 18,631 23,463 25,242 40,807 85,847 62,081 80,661 138,355 122,424
Market Capitalization
11,473 11,667 22,065 26,174 26,389 41,949 86,827 60,984 80,987 139,220 124,330
Book Value per Share
$32.23 $36.93 $42.26 $39.63 $31.17 $35.63 $42.26 $45.26 $61.11 $65.32 $7.71
Tangible Book Value per Share
$18.87 $24.71 $31.12 $28.65 $19.83 $24.25 $30.88 $33.60 $47.78 $51.82 $6.30
Total Capital
7,706 10,428 9,681 8,997 9,213 10,994 11,029 11,284 13,222 13,523 14,346
Total Debt
2,361 4,326 2,693 2,417 4,490 5,811 5,002 5,006 5,012 4,983 4,485
Total Long-Term Debt
1,001 3,378 1,785 1,807 3,823 4,971 4,990 4,998 5,003 4,479 3,730
Net Debt
-1,886 -2,752 -3,604 -2,789 -1,196 -1,153 -980 1,097 -326 -865 -1,906
Capital Expenditures (CapEx)
198 175 156 273 303 203 349 546 502 397 759
Debt-free, Cash-free Net Working Capital (DFCFNWC)
923 915 1,060 1,660 1,425 1,821 2,407 4,070 3,715 3,202 2,312
Debt-free Net Working Capital (DFNWC)
4,999 7,743 7,101 6,610 6,856 8,531 8,136 7,728 9,052 9,050 8,703
Net Working Capital (NWC)
3,639 6,795 6,192 6,000 6,189 7,691 8,125 7,720 9,043 8,545 7,949
Net Nonoperating Expense (NNE)
42 109 85 46 16 86 99 167 58 -85 -51
Net Nonoperating Obligations (NNO)
-1,886 -2,752 -3,604 -2,789 -1,196 -1,153 -980 1,097 -326 -865 -1,906
Total Depreciation and Amortization (D&A)
278 291 332 341 309 269 307 334 342 360 386
Debt-free, Cash-free Net Working Capital to Revenue
17.54% 15.54% 13.22% 14.99% 14.76% 18.13% 16.46% 23.63% 21.31% 21.48% 12.54%
Debt-free Net Working Capital to Revenue
95.05% 131.55% 88.61% 59.67% 71.02% 84.93% 55.63% 44.86% 51.94% 60.71% 47.21%
Net Working Capital to Revenue
69.20% 115.45% 77.27% 54.16% 64.11% 76.57% 55.55% 44.82% 51.89% 57.33% 43.12%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.11 $5.75 $10.47 $14.73 $14.37 $15.55 $27.22 $32.92 $33.30 $29.13 $4.17
Adjusted Weighted Average Basic Shares Outstanding
159.63M 158.92M 162.22M 161.64M 152.48M 144.81M 143.61M 139.90M 135.47M 131.41M 1.29B
Adjusted Diluted Earnings per Share
$3.70 $5.22 $9.24 $13.17 $13.70 $15.10 $26.90 $32.75 $33.21 $29.00 $4.15
Adjusted Weighted Average Diluted Shares Outstanding
177.07M 175.16M 183.77M 180.78M 159.92M 149.09M 145.32M 140.63M 135.83M 132.00M 1.29B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
158.19M 160.26M 162.45M 157.58M 144.53M 145.63M 141.95M 136.99M 132.51M 129.88M 1.27B
Normalized Net Operating Profit after Tax (NOPAT)
768 1,023 1,783 2,427 2,208 2,338 4,008 4,773 4,606 3,743 5,307
Normalized NOPAT Margin
14.60% 17.38% 22.24% 21.91% 22.87% 23.28% 27.40% 27.70% 26.43% 25.11% 28.79%
Pre Tax Income Margin
14.09% 16.31% 22.61% 28.45% 25.34% 25.64% 29.88% 30.15% 29.32% 29.25% 32.32%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.70% 20.83% 14.34% 12.92% 30.95% 29.17% 18.60% 17.70% 20.13% 26.62% 21.45%
Augmented Payout Ratio
105.14% 38.16% 62.15% 124.37% 203.47% 90.00% 87.62% 101.64% 64.84% 100.89% 85.32%

Quarterly Metrics And Ratios for Lam Research

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/24/2023 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026
DEI Shares Outstanding
- - - - - - - - - - 1,248,771,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,248,771,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.46
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-31.38% -28.79% -1.96% 20.71% 19.70% 16.44% 24.43% 33.58% 27.74% 22.14% 23.76%
EBITDA Growth
-35.50% -32.20% 14.80% 30.37% 24.41% 22.61% 38.12% 51.07% 41.21% 34.35% 30.22%
EBIT Growth
-38.02% -34.20% 16.43% 33.67% 26.19% 24.02% 40.57% 54.11% 43.64% 36.23% 30.90%
NOPAT Growth
-39.50% -37.86% 14.33% 25.38% 23.20% 26.97% 44.80% 69.07% 41.52% 33.32% 37.36%
Net Income Growth
-37.76% -35.02% 18.65% 27.13% 25.81% 24.81% 37.78% 68.59% 40.51% 33.83% 37.18%
EPS Growth
-37.76% -35.02% 22.13% 28.81% 25.81% 27.78% 41.10% 71.79% 44.19% 36.96% 40.78%
Operating Cash Flow Growth
-20.04% 27.51% -19.79% -23.18% 64.90% -48.97% -5.50% 196.16% 13.42% 99.48% -12.78%
Free Cash Flow Firm Growth
314.17% 268.53% 354.85% 323.80% 97.59% -66.00% -89.88% 16.39% -39.91% 100.61% 491.78%
Invested Capital Growth
1.12% -10.63% -5.89% -2.66% -6.18% 7.36% 16.52% 3.66% 8.06% 3.99% 11.98%
Revenue Q/Q Growth
8.57% 7.93% 0.94% 2.05% 7.66% 4.99% 7.86% 9.56% 2.95% 0.39% 9.29%
EBITDA Q/Q Growth
17.09% 5.54% 0.43% 5.04% 11.74% 4.02% 13.14% 14.89% 4.44% -1.03% 9.65%
EBIT Q/Q Growth
18.76% 5.99% 0.56% 5.60% 12.12% 4.16% 13.99% 15.76% 4.51% -1.21% 9.53%
NOPAT Q/Q Growth
11.46% 4.85% 0.63% 6.61% 9.52% 8.06% 14.76% 24.49% -8.33% 1.80% 18.24%
Net Income Q/Q Growth
10.57% 7.54% 1.21% 5.64% 9.43% 6.68% 11.73% 29.27% -8.80% 1.62% 14.52%
EPS Q/Q Growth
10.57% 7.54% 1.66% 5.99% 9.43% 6.98% 11.96% 30.10% -7.46% 1.61% 15.08%
Operating Cash Flow Q/Q Growth
-15.28% 52.85% -4.75% -37.72% 81.87% -52.70% 76.38% 95.18% -30.35% -16.80% -22.88%
Free Cash Flow Firm Q/Q Growth
180.64% 129.07% -23.81% -13.48% 30.84% -60.58% -77.33% 895.44% -32.44% 31.59% -33.13%
Invested Capital Q/Q Growth
-0.12% -3.89% -3.10% 4.66% -3.74% 9.97% 5.17% -6.90% 0.35% 5.83% 13.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.52% 46.76% 47.46% 47.53% 48.05% 47.37% 49.02% 50.08% 50.43% 49.60% 49.83%
EBITDA Margin
32.05% 31.34% 31.19% 32.10% 33.32% 33.01% 34.62% 36.30% 36.83% 36.31% 36.43%
Operating Margin
29.38% 28.13% 27.87% 29.10% 30.33% 30.48% 33.09% 33.67% 34.35% 33.87% 35.04%
EBIT Margin
29.45% 28.92% 28.82% 29.82% 31.05% 30.81% 32.56% 34.40% 34.92% 34.36% 34.44%
Profit (Net Income) Margin
25.48% 25.39% 25.46% 26.35% 26.79% 27.22% 28.19% 33.26% 29.46% 29.82% 31.25%
Tax Burden Percent
86.52% 87.78% 88.35% 88.39% 86.26% 88.34% 86.59% 96.69% 84.37% 86.79% 90.75%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
13.48% 12.22% 11.65% 11.61% 13.74% 11.66% 13.41% 3.31% 15.63% 13.21% 9.25%
Return on Invested Capital (ROIC)
51.40% 44.09% 46.36% 49.28% 53.45% 55.63% 61.84% 76.79% 73.89% 72.93% 76.13%
ROIC Less NNEP Spread (ROIC-NNEP)
53.62% 33.40% 41.47% 45.15% 49.32% 53.74% 64.46% 74.15% 72.35% 71.00% 79.38%
Return on Net Nonoperating Assets (RNNOA)
0.70% -0.99% -3.29% -3.21% -3.75% -4.22% -6.09% -11.17% -12.76% -8.92% -7.83%
Return on Equity (ROE)
52.11% 43.10% 43.07% 46.07% 49.70% 51.41% 55.75% 65.63% 61.12% 64.02% 68.30%
Cash Return on Invested Capital (CROIC)
49.84% 53.94% 52.90% 50.81% 58.12% 46.41% 42.90% 64.31% 67.19% 70.33% 62.19%
Operating Return on Assets (OROA)
25.04% 21.80% 21.87% 23.69% 25.43% 25.86% 29.17% 31.64% 33.02% 34.27% 36.64%
Return on Assets (ROA)
21.66% 19.14% 19.33% 20.94% 21.94% 22.84% 25.26% 30.59% 27.86% 29.74% 33.25%
Return on Common Equity (ROCE)
52.11% 43.10% 43.07% 46.07% 49.70% 51.41% 55.75% 65.63% 61.12% 64.02% 68.30%
Return on Equity Simple (ROE_SIMPLE)
49.36% 42.06% 45.00% 0.00% 47.89% 48.75% 48.98% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
885 928 934 996 1,090 1,178 1,352 1,683 1,543 1,571 1,858
NOPAT Margin
25.42% 24.69% 24.62% 25.72% 26.16% 26.93% 28.65% 32.55% 28.99% 29.39% 31.80%
Net Nonoperating Expense Percent (NNEP)
-2.22% 10.69% 4.89% 4.13% 4.13% 1.88% -2.62% 2.64% 1.54% 1.93% -3.25%
Return On Investment Capital (ROIC_SIMPLE)
- 7.03% - - - 8.55% 9.66% 11.73% 10.52% 10.74% 12.97%
Cost of Revenue to Revenue
52.48% 53.24% 52.54% 52.47% 51.95% 52.63% 50.98% 49.92% 49.57% 50.40% 50.17%
SG&A Expenses to Revenue
5.95% 6.09% 5.69% 5.59% 5.83% 5.58% 4.79% 5.19% 5.25% 5.01% 4.80%
R&D to Revenue
12.14% 12.50% 13.50% 12.86% 11.88% 11.31% 11.14% 11.22% 10.83% 10.73% 9.98%
Operating Expenses to Revenue
18.14% 18.63% 19.60% 18.43% 17.72% 16.89% 15.93% 16.41% 16.07% 15.73% 14.78%
Earnings before Interest and Taxes (EBIT)
1,026 1,087 1,093 1,154 1,294 1,348 1,537 1,779 1,859 1,837 2,012
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,116 1,178 1,183 1,243 1,389 1,444 1,634 1,877 1,961 1,941 2,128
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
10.10 12.38 15.85 16.30 12.68 10.72 9.80 12.61 15.93 22.05 24.94
Price to Tangible Book Value (P/TBV)
12.97 15.79 20.33 20.55 16.00 13.40 12.08 15.44 19.41 27.01 30.34
Price to Revenue (P/Rev)
5.13 7.11 8.93 9.34 6.89 5.83 5.44 6.74 8.29 10.88 12.18
Price to Earnings (P/E)
20.45 29.43 35.22 36.37 26.48 22.00 20.01 23.20 27.95 36.00 39.36
Dividend Yield
1.17% 0.96% 0.80% 0.75% 1.00% 1.17% 1.23% 0.95% 0.74% 0.68% 0.48%
Earnings Yield
4.89% 3.40% 2.84% 2.75% 3.78% 4.55% 5.00% 4.31% 3.58% 2.78% 2.54%
Enterprise Value to Invested Capital (EV/IC)
10.29 13.36 17.24 18.03 14.39 11.54 10.80 15.39 20.07 26.27 27.49
Enterprise Value to Revenue (EV/Rev)
5.12 7.06 8.88 9.28 6.82 5.78 5.38 6.64 8.18 10.80 12.13
Enterprise Value to EBITDA (EV/EBITDA)
16.76 23.63 28.54 29.31 21.30 17.83 16.16 19.30 23.16 29.94 33.26
Enterprise Value to EBIT (EV/EBIT)
18.10 25.82 31.07 31.73 22.97 19.17 17.29 20.55 24.56 31.66 35.13
Enterprise Value to NOPAT (EV/NOPAT)
20.32 29.52 35.71 36.96 26.93 22.33 19.98 23.07 27.82 36.08 39.51
Enterprise Value to Operating Cash Flow (EV/OCF)
16.41 19.24 25.74 29.74 20.18 20.57 20.58 19.83 25.10 31.17 37.81
Enterprise Value to Free Cash Flow (EV/FCFF)
20.77 23.38 31.61 35.00 23.98 25.74 27.08 24.36 31.02 38.08 46.70
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.62 0.61 0.62 0.58 0.59 0.57 0.47 0.45 0.44 0.44 0.35
Long-Term Debt to Equity
0.62 0.61 0.56 0.52 0.53 0.51 0.39 0.38 0.37 0.37 0.35
Financial Leverage
0.01 -0.03 -0.08 -0.07 -0.08 -0.08 -0.09 -0.15 -0.18 -0.13 -0.10
Leverage Ratio
2.41 2.30 2.28 2.24 2.30 2.27 2.18 2.18 2.22 2.18 2.03
Compound Leverage Factor
2.41 2.30 2.28 2.24 2.30 2.27 2.18 2.18 2.22 2.18 2.03
Debt to Total Capital
38.25% 37.74% 38.32% 36.85% 37.04% 36.13% 32.04% 31.26% 30.55% 30.65% 26.08%
Short-Term Debt to Total Capital
0.03% 0.03% 3.88% 3.73% 3.75% 3.66% 5.39% 5.26% 5.14% 5.15% 0.03%
Long-Term Debt to Total Capital
38.22% 37.71% 34.43% 33.12% 33.29% 32.47% 26.65% 26.00% 25.41% 25.50% 26.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
61.75% 62.26% 61.68% 63.15% 62.96% 63.87% 67.96% 68.74% 69.45% 69.35% 73.92%
Debt to EBITDA
1.03 1.17 1.12 1.06 1.00 0.95 0.79 0.71 0.65 0.60 0.47
Net Debt to EBITDA
-0.04 -0.15 -0.16 -0.18 -0.22 -0.13 -0.17 -0.30 -0.32 -0.23 -0.13
Long-Term Debt to EBITDA
1.03 1.16 1.01 0.95 0.90 0.85 0.65 0.59 0.54 0.50 0.47
Debt to NOPAT
1.25 1.46 1.41 1.33 1.26 1.19 0.97 0.85 0.78 0.73 0.56
Net Debt to NOPAT
-0.04 -0.19 -0.19 -0.23 -0.27 -0.16 -0.21 -0.36 -0.38 -0.28 -0.15
Long-Term Debt to NOPAT
1.25 1.45 1.26 1.20 1.13 1.07 0.81 0.70 0.65 0.61 0.56
Altman Z-Score
7.96 9.04 10.78 11.58 9.18 8.55 8.87 9.98 11.87 15.68 19.57
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.06 3.06 2.82 2.97 2.53 2.54 2.45 2.21 2.21 2.26 2.54
Quick Ratio
1.88 1.95 1.78 1.93 1.69 1.68 1.58 1.49 1.54 1.56 1.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
798 1,829 1,393 1,205 1,577 622 141 1,403 948 1,247 834
Operating Cash Flow to CapEx
1,235.41% 1,261.18% 1,336.02% 856.03% 1,418.30% 393.92% 454.31% 1,483.35% 960.97% 567.33% 344.21%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.85 0.75 0.76 0.79 0.82 0.84 0.90 0.92 0.95 1.00 1.06
Accounts Receivable Turnover
4.29 4.22 5.21 5.58 5.42 5.39 6.31 6.25 5.96 6.05 5.89
Inventory Turnover
1.92 1.70 1.64 1.74 1.83 1.93 2.03 2.22 2.39 2.46 2.56
Fixed Asset Turnover
8.27 0.00 0.00 7.43 7.21 7.27 7.53 8.04 8.29 8.18 8.30
Accounts Payable Turnover
10.44 11.05 13.36 14.48 13.29 12.85 12.86 12.88 12.67 11.16 11.27
Days Sales Outstanding (DSO)
85.06 86.39 70.04 65.41 67.28 67.69 57.85 58.38 61.20 60.33 61.96
Days Inventory Outstanding (DIO)
190.15 215.28 221.91 209.96 199.59 188.85 180.04 164.54 152.63 148.46 142.41
Days Payable Outstanding (DPO)
34.96 33.03 27.33 25.21 27.46 28.41 28.38 28.33 28.81 32.70 32.39
Cash Conversion Cycle (CCC)
240.25 268.65 264.62 250.17 239.42 228.13 209.51 194.59 185.02 176.09 171.98
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,875 7,568 7,333 7,675 7,388 8,125 8,545 7,955 7,984 8,449 9,568
Invested Capital Turnover
2.02 1.79 1.88 1.92 2.04 2.07 2.16 2.36 2.55 2.48 2.39
Increase / (Decrease) in Invested Capital
87 -900 -459 -210 -487 557 1,211 281 595 324 1,024
Enterprise Value (EV)
81,069 101,107 126,449 138,355 106,339 93,760 92,240 122,424 160,208 221,965 262,986
Market Capitalization
81,241 101,761 127,138 139,220 107,423 94,443 93,207 124,330 162,417 223,661 264,003
Book Value per Share
$60.73 $62.39 $61.19 $65.32 $65.23 $6.85 $7.41 $7.71 $8.05 $8.08 $8.48
Tangible Book Value per Share
$47.27 $48.90 $47.70 $51.82 $51.69 $5.48 $6.01 $6.30 $6.61 $6.59 $6.97
Total Capital
13,032 13,206 13,006 13,523 13,456 13,790 13,995 14,346 14,677 14,629 14,319
Total Debt
4,984 4,984 4,983 4,983 4,984 4,982 4,484 4,485 4,484 4,484 3,734
Total Long-Term Debt
4,980 4,980 4,478 4,479 4,479 4,478 3,730 3,730 3,730 3,730 3,730
Net Debt
-172 -654 -689 -865 -1,084 -683 -966 -1,906 -2,209 -1,697 -1,016
Capital Expenditures (CapEx)
77 115 104 101 111 188 288 172 185 261 332
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,594 3,148 2,891 3,202 2,587 3,101 3,274 2,312 2,160 2,378 3,308
Debt-free Net Working Capital (DFNWC)
8,750 8,786 8,563 9,050 8,654 8,767 8,725 8,703 8,853 8,559 8,059
Net Working Capital (NWC)
8,746 8,782 8,058 8,545 8,150 8,263 7,970 7,949 8,099 7,805 8,055
Net Nonoperating Expense (NNE)
-2.25 -26 -32 -25 -26 -13 22 -37 -25 -23 32
Net Nonoperating Obligations (NNO)
-172 -654 -689 -865 -1,084 -683 -966 -1,906 -2,209 -1,697 -1,016
Total Depreciation and Amortization (D&A)
90 91 90 88 94 96 97 98 102 104 116
Debt-free, Cash-free Net Working Capital to Revenue
22.69% 21.99% 20.30% 21.48% 16.59% 19.13% 19.11% 12.54% 11.03% 11.57% 15.26%
Debt-free Net Working Capital to Revenue
55.25% 61.37% 60.13% 60.71% 55.51% 54.09% 50.92% 47.21% 45.19% 41.63% 37.17%
Net Working Capital to Revenue
55.23% 61.34% 56.59% 57.33% 52.27% 50.97% 46.51% 43.12% 41.34% 37.96% 37.15%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.67 $0.73 $7.38 $7.81 $0.86 $0.93 $1.04 $1.34 $1.24 $1.27 $1.46
Adjusted Weighted Average Basic Shares Outstanding
1.33B 1.32B 130.84M 131.41M 1.30B 1.29B 1.28B 1.29B 1.26B 1.25B 1.25B
Adjusted Diluted Earnings per Share
$0.67 $0.72 $7.34 $7.78 $0.86 $0.92 $1.03 $1.34 $1.24 $1.26 $1.45
Adjusted Weighted Average Diluted Shares Outstanding
1.33B 1.32B 131.52M 132.00M 1.30B 1.29B 1.29B 1.29B 1.27B 1.26B 1.26B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.34 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.32B 1.31B 130.74M 129.88M 1.29B 1.28B 1.28B 1.27B 1.26B 1.25B 1.25B
Normalized Net Operating Profit after Tax (NOPAT)
885 928 947 996 1,090 1,178 1,352 1,683 1,543 1,571 1,858
Normalized NOPAT Margin
25.42% 24.69% 24.97% 25.72% 26.16% 26.93% 28.65% 32.55% 28.99% 29.39% 31.80%
Pre Tax Income Margin
29.45% 28.92% 28.82% 29.82% 31.05% 30.81% 32.56% 34.40% 34.92% 34.36% 34.44%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
23.48% 27.79% 27.42% 26.62% 25.87% 25.22% 23.95% 21.45% 20.32% 19.48% 18.49%
Augmented Payout Ratio
92.72% 112.80% 119.89% 100.89% 99.74% 96.23% 77.70% 85.32% 78.85% 86.59% 91.49%

Financials Breakdown Chart

Key Financial Trends

Lam Research (LRCX) has shown durable cash generation and a solid balance sheet over the last four years, with profits and cash flow supported by ongoing semiconductors equipment demand. The company also maintains meaningful liquidity and a history of returning capital to shareholders, though it continues to invest heavily in capex and R&D to sustain growth.

  • Operating cash flow remains robust across recent quarters, underscoring strong cash generation even through cyclical periods.
  • Liquidity is ample, with cash & equivalents typically around $6B+, and a solid working capital cushion (current assets well above current liabilities).
  • Profitability is solid, as seen in recent quarters with meaningful net income and healthy gross margins contributing to tangible per-share earnings.
  • The balance sheet shows a strong current asset position and manageable leverage, with cash largely outweighing near-term debt obligations.
  • Shareholder returns remain a focus, including sizable share repurchases and recurring dividends over multiple periods.
  • R&D and capital expenditures remain a core strategic focus, contributing to near-term cash outflows as the company invests in technology leadership.
  • Several quarterly results include restatements or restated figures, which can affect comparability across periods.
  • Operating assets and liabilities tend to swing quarter to quarter, leading to some cash-flow volatility related to working capital movements.
  • Significant financing outflows from share repurchases and dividends have weighed on cash flow from financing, especially when combined with other uses of cash.
  • Capex intensity remains meaningful, which, while appropriate for growth, reduces near-term free cash flow during downturns or weaker cycles.
05/09/26 05:14 AM ETAI Generated. May Contain Errors.

Lam Research Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lam Research's financial year ends in June. Their financial year 2025 ended on June 29, 2025.

Lam Research's net income appears to be on an upward trend, with a most recent value of $5.36 billion in 2025, rising from $655.58 million in 2015. The previous period was $3.83 billion in 2024. View Lam Research's forecast to see where analysts expect Lam Research to go next.

Lam Research's total operating income in 2025 was $5.90 billion, based on the following breakdown:
  • Total Gross Profit: $8.98 billion
  • Total Operating Expenses: $3.08 billion

Over the last 10 years, Lam Research's total revenue changed from $5.26 billion in 2015 to $18.44 billion in 2025, a change of 250.5%.

Lam Research's total liabilities were at $11.48 billion at the end of 2025, a 12.5% increase from 2024, and a 185.7% increase since 2015.

In the past 10 years, Lam Research's cash and equivalents has ranged from $1.50 billion in 2015 to $6.39 billion in 2025, and is currently $6.39 billion as of their latest financial filing in 2025.

Over the last 10 years, Lam Research's book value per share changed from 32.23 in 2015 to 7.71 in 2025, a change of -76.1%.



Financial statements for NASDAQ:LRCX last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners